160 related articles for article (PubMed ID: 12014712)
21. [Treatment of acute hepatitis C].
García Compeán D
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S61-6. PubMed ID: 12712857
[TBL] [Abstract][Full Text] [Related]
22. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
Watashi K; Metselaar HJ; van der Laan LJ
Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373
[No Abstract] [Full Text] [Related]
23. [Treatment of hepatitis C. Different modalities based on viral genotype].
Pariente A
Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
[No Abstract] [Full Text] [Related]
24. New kinetic models for the hepatitis C virus.
Perelson AS; Herrmann E; Micol F; Zeuzem S
Hepatology; 2005 Oct; 42(4):749-54. PubMed ID: 16175615
[TBL] [Abstract][Full Text] [Related]
25. Aspects of the future of therapy for patients infected with a high viral load and interferon-resistant subtype of HCV.
Matsumoto A; Kiyosawa K
J Gastroenterol; 2002; 37(9):766-8. PubMed ID: 12375156
[No Abstract] [Full Text] [Related]
26. Current and future concepts in hepatitis C therapy.
Pawlotsky JM
Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
[TBL] [Abstract][Full Text] [Related]
27. Genetic factors predicting response to interferon treatment for viral hepatitis C.
Stärkel P
Gut; 2008 Apr; 57(4):440-2. PubMed ID: 18334658
[No Abstract] [Full Text] [Related]
28. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic prospects in HCV treatment.
Almasio PL; Ingrassia D; Vergara B; Filosto S
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):775-9. PubMed ID: 19053890
[No Abstract] [Full Text] [Related]
30. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
31. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
32. A la carte interferon for hepatitis C?
Marcellin P; Benhamou JP; Heathcote J; Bismuth H; Desmet V; Guardia J; Lok A; Buschenfeld KH; Pagliaro L; Paumgartner G; Rodes J; Sherlock S
Hepatology; 2000 Sep; 32(3):678-9. PubMed ID: 10991636
[No Abstract] [Full Text] [Related]
33. [Criteria to hepatitis C treatment response].
Levi D; Tanno H; Descalzi V
Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S50-2; discussion S74-82. PubMed ID: 16862861
[No Abstract] [Full Text] [Related]
34. Infection fighters. Hepatitis C and HIV.
TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
[No Abstract] [Full Text] [Related]
35. Viral kinetics in hepatitis C.
Lutchman G; Hoofnagle JH
Hepatology; 2003 Jun; 37(6):1257-9. PubMed ID: 12774002
[No Abstract] [Full Text] [Related]
36. Alternative interferons and immunomodulators in the treatment of hepatitis C.
Alao H; Jake Liang T
Liver Int; 2014 Feb; 34 Suppl 1():133-8. PubMed ID: 24373090
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
38. Treatment predictors of a sustained virologic response in hepatitis B and C.
Kau A; Vermehren J; Sarrazin C
J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
[TBL] [Abstract][Full Text] [Related]
39. HCV genotype 5: epidemiology and spread of an uncommon genotype.
Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
[No Abstract] [Full Text] [Related]
40. Tailored treatment for hepatitis C.
Berg T
Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
